Vagal dysregulation in COPD may contribute to increased cough reflex sensitivity and airway parasympathetic activity, suggesting a potential therapeutic role for drugs targeting neuronal activity.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for vagal-targeted therapies in COPD cough; prospective trials needed before clinical adoption.
Undem et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: